Axcella Health Inc. - Common Stock (NQ:AXLA)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Nov 22, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Axcella Health Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study ↗

August 02, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Axcella's NASH Candidate Shows Favorable Action In Long COVID-Related Fatigue ↗

August 02, 2022

Via Benzinga

Axcella Announces Highly Promising Results from Phase 2a Placebo Controlled Clinical Trial for Long COVID

August 02, 2022

From Axcella Therapeutics

Via Business Wire

12 Health Care Stocks Moving In Friday's After-Market Session ↗

July 29, 2022

Gainers Nanobiotix (NASDAQ:NBTX) shares rose 16.4% to $2.7 during Friday's after-market session. The company's market cap stands at $94.1 million.

Via Benzinga

Recap: Axcella Health Q1 Earnings ↗

May 05, 2022

Axcella Health (NASDAQ:AXLA) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Axcella Health: Q4 Earnings Insights ↗

March 30, 2022

Axcella Health (NASDAQ:AXLA) reported its Q4 earnings results on Wednesday, March 30, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Via Benzinga

From Axcella To Tonix, Here Are The Penny Stocks Of Companies Working On Long Covid ↗

June 27, 2022

More than four in 10 people in a recent survey knew of someone with long Covid.

Via Investor's Business Daily

89 Biggest Movers From Friday ↗

June 21, 2022

Gainers Revlon, Inc. (NYSE: REV) jumped 91.3% to close at $3.73 on Friday after the company filed for Chapter 11 bankruptcy.

Via Benzinga

91 Biggest Movers From Friday ↗

June 13, 2022

Gainers RISE Education Cayman Ltd (NYSE: REDU) shares jumped 138.5% to settle at $3.41 on Friday. RISE Education announced expected timing for the completion of the merger with Dada Auto.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

June 10, 2022

Via Benzinga

Axcella Announces Completion of Enrollment of Clinical Trial for Long COVID and Has Prioritized its Clinical Portfolio

May 26, 2022

From Axcella Therapeutics

Via Business Wire

Axcella Therapeutics to Participate in the H.C. Wainwright Global Investment Conference

May 19, 2022

From Axcella Therapeutics

Via Business Wire

Axcella Reports First Quarter Financial Results and Provides Business Update

May 05, 2022

From Axcella Therapeutics

Via Business Wire

Earnings Scheduled For March 30, 2022 ↗

March 30, 2022

Companies Reporting Before The Bell • Orgenesis (NASDAQ:ORGS) is likely to report earnings for its fourth quarter. • RumbleON (NASDAQ:RMBL) is estimated to report earnings for its Fiscal Year 2021.

Via Benzinga

Axcella Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

March 30, 2022

From Axcella Therapeutics

Via Business Wire

Preview: Axcella Health's Earnings ↗

March 29, 2022

Axcella Health (NASDAQ:AXLA) is set to give its latest quarterly earnings report on Wednesday, 2022-03-30. Here's what investors need to know before the announcement. Analysts estimate that Axcella...

Via Benzinga

The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More ↗

March 27, 2022

Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money out of defensives and into risky bets.

Via Benzinga

Drug makers, Scientists Working For Long COVID Treatments: Reuters ↗

March 25, 2022

Researchers and drugmakers, including those who have launched antiviral pills and monoclonal antibodies for COVID-19, are having early discussions about targeting Long COVID,

Via Benzinga

Axcella Health Earnings Conference Call Is Coming Up, Here's What You Need To Know ↗

March 24, 2022

Axcella Health (NASDAQ:AXLA) will host a conference call at 08:30 AM ET on March 30, 2022, to discuss Q4 2021 earnings results. How to Attend Axcella Health (AXLA) Conference Call...

Via Benzinga

Axcella to Report Fourth Quarter and Year End 2021 Financial Results on March 30, 2022

March 23, 2022

From Axcella Therapeutics

Via Business Wire

Executives Buy Around $16M Of 4 Penny Stocks ↗

March 21, 2022

US stocks closed higher with the Nasdaq Composite jumping over 2% on Friday. Investors, meanwhile, focused on some notable insider trades

Via Benzinga

31 Stocks Moving In Thursday's Mid-Day Session ↗

March 17, 2022

Gainers TD Holdings, Inc. (NASDAQ: GLG) rose 83.2% to $0.4348 after the company reported FY21 results. Allego N.V. (NASDAQ: ALLG) shares gained 45.5% to $9.40. Spartan...

Via Benzinga

64 Biggest Movers From Yesterday ↗

March 18, 2022

Gainers Kidpik Corp. (NASDAQ: PIK) shares surged 158.2% to settle at $4.75 on Thursday after the company announced a partnership with The Walt Disney Co. Cuentas Inc. (NASDAQ:...

Via Benzinga

Insiders Buy Over $7M Of 3 Penny Stocks ↗

March 17, 2022

The US Federal Reserve, on Wednesday, raised its target fed funds rate by 0.25%, its first interest rate hike since 2018. Investors, meanwhile, focused on some notable insider trades

Via Benzinga

Axcella Therapeutics Announces $25 Million Registered Direct Offering of Common Stock Priced At The Market

March 16, 2022

From Axcella Therapeutics

Via Business Wire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

March 07, 2022

Gainers TherapeuticsMD (NASDAQ:TXMD) stock increased by 56.5% to $0.33 during Monday's pre-market session. The company's market cap stands at $139.7 million....

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

February 25, 2022

Gainers Kaleido Biosciences (NASDAQ:KLDO) stock rose 14.6% to $1.73 during Friday's pre-market session. The market value of their outstanding shares is at $73.6...

Via Benzinga

Axcella Therapeutics Announces FDA Fast Track Designation for AXA1125 in NASH

February 14, 2022

From Axcella Therapeutics

Via Business Wire

Axcella Therapeutics to Participate in the SVB Leerink Global Healthcare Conference

February 10, 2022

From Axcella Therapeutics

Via Business Wire

Axcella Therapeutics Announces Appointment of New Chief Financial Officer

February 07, 2022

From Axcella Therapeutics

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.